Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07115953 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension

Study acronym: SWYFT
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study sites: 19 to 21v10
  2. Study sites revised (19)v9 See this version in full on ClinicalTrials.gov ↗
  3. Site details revised at 1 of 19 sitesv8
  4. Study sites: 18 to 19v7
  5. Study sites: 17 to 18v6
Show 4 earlier versionsHide 4 earlier versions
  1. Study sites: 16 to 17v5
  2. Study sites: 15 to 16v4
  3. Study sites: 4 to 15 Start date changed from estimate of Aug 27, 2025 to Sep 22, 2025v3 Show 1 more changeShow less
    • Start date changed from estimate of Aug 27, 2025 to Sep 22, 2025
  4. Trial status: Not Yet Recruiting to Recruiting Primary endpoints revised (2) · Study sites: 0 to 4 · Start date: Aug 15, 2025 to Aug 27, 2025 · 1 morev2 Show 4 more changesShow less
    • Primary endpoints revised (2)
    • Study sites: 0 to 4
    • Start date: Aug 15, 2025 to Aug 27, 2025
    • Secondary endpoints: details revised at 1 of 10 entries

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Medtronic Vascular
11 trials monitored
See all monitored trials
Diabetes
4,286 trials monitored
See 187 trials at risk
Heart Disease
2,136 trials monitored
See 109 trials at risk
Hypertension
1,795 trials monitored
See 85 trials at risk
and 1 more disease
The purpose of the SPYRAL SWYFT sub-study is to evaluate whether renal denervation with the Symplicity Spyral system performed in the main and first order branch renal arteries yields a shorter procedure time and is as effective in reducing blood pressure than the procedural approach used in the SPYRAL HTN-ON MED and SPYRAL PIVOTAL - SPYRAL HTN-OFF MED clinical studies in an uncontrolled hypertensive population.
Trial Details
NCT Number NCT07115953
Lead Sponsor Medtronic Vascular
Conditions Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases, Diabetes Mellitus
Enrollment 130 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov